Winton Group’s Zosano Pharma Corporation ZSAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-1,845
Closed -$80K 1549
2021
Q1
$80K Sell
1,845
-66
-3% -$2.76K ﹤0.01% 1342
2020
Q4
$35K Sell
1,911
-1,523
-44% -$29.8K ﹤0.01% 1295
2020
Q3
$195K Buy
3,434
+2,796
+438% +$130K 0.01% 1351
2020
Q2
$19K Buy
+638
New +$18K ﹤0.01% 1426
2020
Q1
Sell
-292
Closed -$16K 1593
2019
Q4
$16K Sell
292
-1,182
-80% -$72.9K ﹤0.01% 1514
2019
Q3
$80K Buy
+1,474
New +$132K ﹤0.01% 1477

Other funds holding ZSAN

Winton Group's ZSAN Position: Q2 2021 in Review

Winton Group sold out of Zosano Pharma Corporation (ZSAN) in Q2 2021, closing a stake of 1,845 shares — an estimated $80K sold.

Winton Group first reported a position in ZSAN in Q3 2019 and held it in 6 quarters. The position peaked at $195K in Q3 2020. 34 funds tracked by Wall St. Rank hold ZSAN as of Q2 2021.

  • Winton Group reported no remaining Zosano Pharma Corporation position as of Q2 2021 after selling out during the quarter.
  • Winton Group sold 1,845 Zosano Pharma Corporation shares in Q2 2021, an estimated $80K.
  • Winton Group first reported a position in Zosano Pharma Corporation in Q3 2019 and held it in 6 quarters.
  • Winton Group's Zosano Pharma Corporation position peaked at $195K in Q3 2020.
  • 34 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q2 2021.

Based on Winton Group's 13F filing for Q2 2021, filed 10 Aug 2021.